WuXi Forms JV With PRA To Expand Clinical Services In China
This article was originally published in PharmAsia News
Executive Summary
WuXi PharmaTech forms a joint venture with U.S. contract research organization PRA to grow its clinical capabilities in China; the move expands PRA’s reach to 16 Chinese cities.